Lung Cancer
Lung cancer genetic abnormalities detected by FISH analysis
Published in Cancer Weekly, June 27th, 2006
According to recent research from Austria, "Detection of molecular abnormalities could provide an essential tool for the diagnosis of non-small cell lung cancer (NSCLC) and defining patients at risk for early relapse. FISH targeting 17 gene loci was applied to determine the frequency of molecular alteration in NSCLC probes and adjacent tumour-free bronchial epithelium."
"FISH was performed on fresh frozen specimens from 76 patients with histologically confirmed NSCLC and 54 specimens of adjacent tumour-free tissue," explained W. Hilbe and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-27)
More Articles from Cancer Weekly
- Apoptosis
Erythropoietin is unlikely to disrupt effectiveness of cancer chemotherapeutic drugs - Childhood Cancer
Neuroblastoma in offspring linked to maternal use of recreational drugs - Infection Management
Infection management is challenging in cancer and stem cell transplant patients - Prostate Cancer
Prostate cancer prevented with selenium accumulation in prostate tissue - Tumor Research
Storing freshly resected tumors in oxygen-enriched solution may aid in tumor research - AIDS-Associated Kaposi Sarcoma
AIDS-associated KS prognostic index predicts mortality at initial diagnosis - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
